Patents by Inventor Michael Nedved

Michael Nedved has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for Producing Anti-TNF Antibody Compositions
    Publication number: 20250066465
    Abstract: Presented here are methods for producing a recombinant anti-TNF antibody having a heavy chain (HC) comprising SEQ ID NO:38 and a light chain (LC) comprising SEQ ID NO:37 and compositions comprising the recombinant anti-TNF antibody.
    Type: Application
    Filed: September 12, 2024
    Publication date: February 27, 2025
    Inventors: Kristopher Barnthouse, Subinay Ganguly, Maarten Groeneveld, Manuel Lopez, JR., Michael Nedved, Kevin D. Smith
  • Manufacturing Methods for Producing Anti-TNF Antibody Compositions
    Publication number: 20250019428
    Abstract: The present invention relates to methods of manufacture for producing anti-TNF antibodies, e.g., the anti-TNF antibody a recombinant anti-TNF antibody having a heavy chain (HC) comprising amino acid sequence SEQ ID NO:36 and a light chain (LC) comprising amino acid sequence SEQ ID NO:37 and compositions comprising the recombinant anti-TNF antibody.
    Type: Application
    Filed: July 8, 2024
    Publication date: January 16, 2025
    Inventors: Kristopher Barnthouse, Subinay Ganguly, Maarten Groeneveld, Manuel Lopez, JR., Michael Nedved, Kevin D. Smith
  • Methods for Producing Anti-TNF Antibody Compositions
    Publication number: 20250019429
    Abstract: Presented here are methods for producing a recombinant anti-TNF antibody having a heavy chain (HC) comprising SEQ ID NO:38 and a light chain (LC) comprising SEQ ID NO:37 and compositions comprising the recombinant anti-TNF antibody.
    Type: Application
    Filed: September 23, 2024
    Publication date: January 16, 2025
    Inventors: Kristopher Barnthouse, Subinay Ganguly, Maarten Groeneveld, Manuel Lopez, JR., Michael Nedved, Kevin D. Smith
  • Manufacturing methods for producing anti-TNF antibody compositions
    Patent number: 12180271
    Abstract: The present invention relates to methods of manufacture for producing anti-TNF antibodies, e.g., the anti-TNF antibody a recombinant anti-TNF antibody having a heavy chain (HC) comprising amino acid sequence SEQ ID NO:36 and a light chain (LC) comprising amino acid sequence SEQ ID NO:37 and compositions comprising the recombinant anti-TNF antibody.
    Type: Grant
    Filed: February 26, 2020
    Date of Patent: December 31, 2024
    Assignee: Janssen Biotech, Inc.
    Inventors: Kristopher Barnthouse, Subinay Ganguly, Maarten Groeneveld, Manuel Lopez, Jr., Michael Nedved, Kevin D. Smith
  • MANUFACTURING METHODS FOR PRODUCING ANTI-IL12/IL23 ANTIBODY COMPOSITIONS
    Publication number: 20240383976
    Abstract: Methods of manufacture for producing anti-IL-12/IL-23p40 antibodies, e.g., the anti-IL-12/IL-23p40 antibody ustekinumab, in CHO and specific pharmaceutical compositions of the antibody are useful in treating various diseases.
    Type: Application
    Filed: January 30, 2024
    Publication date: November 21, 2024
    Inventors: Kristopher Barnthouse, Subinay Ganguly, Maarten Groeneveld, Manuel Lopez, JR., Michael Nedved, Kevin D. Smith
  • Anti-tumor necrosis factor (TNF) antibodies and compositions thereof
    Patent number: 12129292
    Abstract: Presented here are methods for producing a recombinant anti-TNF antibody having a heavy chain (HC) comprising SEQ ID NO:38 and a light chain (LC) comprising SEQ ID NO:37 and compositions comprising the recombinant anti-TNF antibody.
    Type: Grant
    Filed: February 26, 2020
    Date of Patent: October 29, 2024
    Assignee: Janssen Biotech, Inc.
    Inventors: Kristopher Barnthouse, Subinay Ganguly, Maarten Groeneveld, Manuel Lopez, Michael Nedved, Kevin D. Smith
  • Nucleic acid molecule encoding, and method of producing, a recombinant anti-tumor necrosis factor (TNF) antibody
    Patent number: 12122825
    Abstract: Presented here are methods for producing a recombinant anti-TNF antibody having a heavy chain (HC) comprising SEQ ID NO:38 and a light chain (LC) comprising SEQ ID NO:37 and compositions comprising the recombinant anti-TNF antibody.
    Type: Grant
    Filed: February 26, 2020
    Date of Patent: October 22, 2024
    Assignee: Janssen Biotech, Inc.
    Inventors: Kristopher Barnthouse, Subinay Ganguly, Maarten Groeneveld, Manuel Lopez, Jr., Michael Nedved, Kevin D. Smith
  • Methods for Producing Anti-TNF Antibody Compositions
    Publication number: 20220153829
    Abstract: Presented here are methods for producing a recombinant anti-TNF antibody having a heavy chain (HC) comprising SEQ ID NO:38 and a light chain (LC) comprising SEQ ID NO:37 and compositions comprising the recombinant anti-TNF antibody.
    Type: Application
    Filed: February 26, 2020
    Publication date: May 19, 2022
    Applicant: Janssen Biotech, Inc.
    Inventors: Kristopher Barnthouse, Subinay Ganguly, Maarten Groeneveld, Manuel Lopez, Michael Nedved, Kevin D. Smith
  • Manufacturing Methods for Producing Anti-TNF Antibody Compositions
    Publication number: 20220153830
    Abstract: The present invention relates to methods of manufacture for producing anti-TNF antibodies, e.g., the anti-TNF antibody a recombinant anti-TNF antibody having a heavy chain (HC) comprising amino acid sequence SEQ ID NO:36 and a light chain (LC) comprising amino acid sequence SEQ ID NO:37 and compositions comprising the recombinant anti-TNF antibody.
    Type: Application
    Filed: February 26, 2020
    Publication date: May 19, 2022
    Applicant: Janssen Biotech, Inc.
    Inventors: Kristopher Barnthouse, Subinay Ganguly, Maarten Groeneveld, Manuel Lopez, Michael Nedved, Kevin D. Smith
  • Methods for Producing Anti-TNF Antibody Compositions
    Publication number: 20220144934
    Abstract: Presented here are methods for producing a recombinant anti-TNF antibody having a heavy chain (HC) comprising SEQ ID NO:38 and a light chain (LC) comprising SEQ ID NO:37 and compositions comprising the recombinant anti-TNF antibody.
    Type: Application
    Filed: February 26, 2020
    Publication date: May 12, 2022
    Applicant: Janssen Biotech, Inc.
    Inventors: Kristopher Barnthouse, Subinay Ganguly, Maarten Groeneveld, Manuel Lopez, Michael Nedved, Kevin D. Smith
  • Manufacturing Methods for Producing Anti-IL12/IL23 Antibody Compositions
    Publication number: 20200291107
    Abstract: Methods of manufacture for producing anti-IL-12/IL-23p40 antibodies, e.g., the anti-IL-12/IL-23p40 antibody ustekinumab, in CHO and specific pharmaceutical compositions of the antibody are useful in treating various diseases.
    Type: Application
    Filed: March 12, 2020
    Publication date: September 17, 2020
    Inventors: Kristopher Barnthouse, Subinay Ganguly, Maarten Groeneveld, Manuel Lopez, Michael Nedved, Kevin D. Smith